Johns Hopkins Medicine in Maryland will be the first placement in the United States to house the largest psychedelic research center in the world!
A $17 million dollar start up fund has been privately donated by numerous contributors to the Center for Psychedelic and Consciousness Research.
“We have to take braver and bolder steps if we want to help those suffering from chronic illnesses…By investing in the Johns Hopkins Center, we are investing in the hope that researchers keep proving the benefits of psychedelics – and people will have new ways to heal.” -Alex Cohen (donor from Steven & Alexandra Cohen Foundation)
The Center for Psychedelic and Consciousness
A focus on how psychedelics affect behavior, brain function, learning/memory and the brain’s biology and mood will be one of the primary observances.
The studies will also dive into the use of psychedelic drugs and their direct correlation in the treatment of numerous mental health conditions such as: addiction, PTSD, depression, Alzheimer’s disease and many more.
The center’s director, Roland Griffiths, Ph.D. states: “In addition to studies on new therapeutics, we plant to investigate creativity and well-being in healthy volunteers that we hope will open up new ways to support human thriving.”
The amount of overall research that will be conducted in the center is an extremely large spectrum of health and wellness to life-saving and changing medicinal benefits.
Why Johns Hopkins?
The actual questions should be, Why Not Johns Hopkins?
The more than 125-year history at Johns Hopkins Medicine has procreated what you may call a medical revolution. Modern medical education and advances were and are continued to be made by physicians and scientists under their umbrella.
As an internationally recognized medical system with cutting-edge innovation, Johns Hopkins continues to improve the health of the community and the world by setting the standard of excellence in medical education, research and clinical care.
The Renowned Professor Griffiths to Lead the Research Team
Leading the research team is Professor Roland R. Griffiths, Ph.D. As a professor of psychiatry and behavioral sciences, this man has an acute focus in researching the behavioral and subjective effects of mood-altering drugs.
Griffiffiths accreditations include: author of over 380 articles, trained 50+ postdoctoral research fellows, consultant to National Institutes of Health, developed new psychotropic drugs with pharmaceutical companies, member of the Expert Advisory Panel on Drug Dependence for WHO and much, much more.
Griffiths psychedelic research group was granted regulatory approval by the government back in 2000 to study psychedelics which surfaced profound positive effects as real potential to medicine. The recent funding will help explore that potential that was unlocked nearly 20 years ago
Building an Army
Griffith and his hand-picked team of doctors, researchers and scientists are ecstatic at the opportunity the funding grants their program. It will certainly help provide the infrastructure necessary to boost psychedelic science in a way that it never has experienced before.
Johns Hopkins scientists have already proven promising therapeutic benefits of use of psilocybin (chemical found in magic mushrooms) in the treatment of nicotine addiction, the mitigation of anxiety and depression as well as cancer treatments! If you are interested in donating to Johns Hopkins’ Medicine, click here